Advisory Committee on Dangerous Pathogens (ACDP)
Work plan for 2008/2009
- To formulate a common set of containment measures to apply to animal and human pathogens1, following the review of the regulatory framework for animal pathogens (Callaghan review).
- To complete the revision of the ACDP 1996 guidance: ‘Protection against blood-borne infections in the workplace: HIV and hepatitis’.
- To advise the Department of Health on the type of isolation facilities to be provided within the NHS.
- To maintain oversight of the work plan of the ACDP TSE Working Group.
- To complete the revision of the ACDP 1996 Guidance: ‘Management and Control of Viral Haemorrhagic Fevers’.
- To advise on Safety Performance Indicators, following progress on this with the Containment Level 4 user group.
- To consider the re-categorisation of Polio virus – dependent on the progress of the global polio eradication programme.
- To develop additional guidelines to add to existing ACDP advice on working with influenza viruses, specific to reconstructed 1918 influenza virus, in conjunction with the Scientific Advisory Committee for Genetic Modification.
1As a minimum this will involve revision of ‘The Management, Design & Operation of Microbiological Containment Laboratories’ and ‘The Principles, Design & Operation of Containment Level 4 Laboratories’
Work Plan for the ACDP TSE Working Group 2008/2009
- To review and update as necessary the current TSE guidance* (Annexes C, D, F and J currently under revision and nearing completion)
- To draft an additional annex of the TSE guidance* to provide comprehensive and up-to-date advice on Ophthalmology and CJD infection control. Expected publication of guidance in 2008
- In conjunction with the work of ESAC-Pr†, to consider and draft relevant guidance when necessary on the handling and disposal of single-use surgical instruments
- To draft an additional annex of the TSE guidance* with advice on the handling of samples in neuropathology and histopathology specifically from individuals identified as at risk of CJD. Expected publication of guidance in 2008
- To re-write Annex G of the TSE guidance* on specialist equipment
- To continue to develop a strategy for assessing and managing the risks from multiple blood component transfusions in conjunction with DH, the CJD Incidents Panel and SaBTO
- To respond to any policy issues arising from consideration of recent HPA dentistry studies
- To address issues of risk management as they arise
* The TSE guidance referred to above is the “Transmissible spongiform encephalopathy agents: safe working and the prevention of infection” were available from:
http://www.advisorybodies.doh.gov.uk/acdp/tseguidance/ The guidance was published in 2003 but individual sections are revised as further scientific information becomes available or future policy decisions need to be reflected.
† ESAC-Pr – The Engineering & Science Advisory Committee into the Decontamination of Surgical Instruments including Prion Removal